Dr. Louis Kirby, M.D., medical director for Pivotal Research Centers, agrees; “Pivotal Research is pleased to be part of the study team in assisting GW Medical in their Phase II clinical trials. A new test to diagnose Alzheimer’s disease earlier, such as their LymPro Test, could lead to expedited therapeutic intervention and an improved quality of life for those individuals affected by AD.”
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links